J&J Scores in The First Mesothelioma Trial

Introduction

Although J&J is witnessing a 'win some - lose some' situation in the ovarian cancer lawsuits linked to its Talcum Powder and Shower to Shower talc products, it won the first Mesothelioma case. The decision was taken by a jury in Los Angeles Superior Court rejecting the plaintiff's claim that she developed mesothelioma (a type of cancer of the tissue that lines the lungs, stomach, heart, and other organs) after using J&J's Talcum Powder.

Comments

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

Categories: Philips CPAP/BiPAP/ASV Sleep Apnea Machines

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

…

J&J Scores in The First Mesothelioma Trial